TSXV · SGMD.V
Salona Global Medical Device Corporation
CA$0.22-CA$0.01 (-4.35%)
Salona Global Medical Device Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
Loading market information…
TSXV · LXG.V · CAD
Stock price, earnings
Quote as of Feb 21, 2023, 08:59 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow LexaGene Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
LexaGene Holdings Inc. is a biotechnology company focused on developing and commercializing sophisticated systems for pathogen detection. Their flagship product, MiQLab, is an automated platform engineered to transform pathogen identification within diverse markets, including veterinary and human clinical diagnostics, food and water safety, and various other life science applications. This advanced, automated system is deployed directly at the point of sample collection, offering unparalleled ease of use, high sensitivity, and the capacity to detect a wide range of pathogens. Founded in 2007, the company's headquarters are located in Beverly, Massachusetts.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.22-CA$0.01 (-4.35%)
Salona Global Medical Device Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
CA$1.42-CA$0.04 (-2.74%)
Reunion Neuroscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.96% below the high.
CA$0.30+CA$0.04 (+13.46%)
Antibe Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.02% below the high.
CA$0.20CA$0.00 (0.0%)
EXMceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.23CA$0.00 (0.0%)
Chalice Brands Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.10-CA$0.01 (-4.76%)
RIV Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.29CA$0.00 (0.0%)
Fire & Flower Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 90.33% below the high.
CA$0.13-CA$0.01 (-3.85%)
Cloud DX Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
